Keros Therapeutics (KROS) Short Interest Ratio & Short Volume → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free KROS Stock Alerts $58.28 -0.40 (-0.68%) (As of 12:48 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Keros Therapeutics Short Interest DataCurrent Short Volume2,260,000 sharesPrevious Short Volume2,100,000 sharesChange Vs. Previous Month+7.62%Dollar Volume Sold Short$130.36 millionShort Interest Ratio / Days to Cover6.1Last Record DateApril 15, 2024Outstanding Shares36,070,000 sharesPercentage of Shares Shorted6.27%Today's Trading Volume74,715 sharesAverage Trading Volume402,702 sharesToday's Volume Vs. Average19% Short Selling Keros Therapeutics ? Sign up to receive the latest short interest report for Keros Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKROS Short Interest Over TimeKROS Days to Cover Over TimeKROS Percentage of Float Shorted Over Time Ad Priority GoldBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...Get your free information kit NOW, before it's too late. Keros Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,260,000 shares $130.36 million +7.6%N/A6.1 $57.68 3/31/20242,100,000 shares $139.02 million +9.4%N/A5.1 $66.20 3/15/20241,920,000 shares $129.31 million +6.1%N/A4.3 $67.35 2/29/20241,810,000 shares $122.18 million +1.7%N/A3.8 $67.50 2/15/20241,780,000 shares $104.79 million +0.6%N/A4 $58.87 1/31/20241,770,000 shares $97.99 million +22.1%N/A4 $55.36 Get the Latest News and Ratings for KROS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,450,000 shares $75.63 million +5.8%N/A3.6 $52.16 12/31/20231,370,000 shares $54.47 million -6.2%N/A3.8 $39.76 12/15/20231,460,000 shares $47.48 million +1.4%6.8%4.7 $32.52 11/30/20231,440,000 shares $43.69 million +18.0%6.8%5.3 $30.34 11/15/20231,220,000 shares $38.87 million -5.4%5.7%5.3 $31.86 10/31/20231,290,000 shares $36.82 million +1.6%6.1%6 $28.54 10/15/20231,270,000 shares $35.70 million -3.8%6.0%6.4 $28.11 9/30/20231,320,000 shares $42.08 million +11.9%6.3%7.1 $31.88 9/15/20231,180,000 shares $42.90 million +3.5%5.6%6.8 $36.36 8/31/20231,140,000 shares $40.03 million +0.9%5.4%5.3 $35.11 8/15/20231,130,000 shares $39.28 million +9.7%5.4%5.1 $34.76 7/31/20231,030,000 shares $43.14 million +5.8%4.9%4.6 $41.88 7/15/2023973,400 shares $39.57 million +11.1%4.7%4.6 $40.65 6/30/2023876,100 shares $35.20 million +0.1%4.2%4 $40.18 6/15/2023875,100 shares $33.98 million +6.5%4.2%3.9 $38.83 5/31/2023821,900 shares $39.34 million +19.7%4.0%4.1 $47.86 5/15/2023686,900 shares $32.25 million +12.0%3.3%3.4 $46.95 4/30/2023613,300 shares $27.20 million -0.5%3.0%3 $44.36 4/15/2023616,600 shares $23.92 million -14.3%3.1%2.8 $38.79 3/31/2023719,700 shares $30.73 million +2.2%3.6%3.2 $42.70 3/15/2023704,500 shares $30.67 million +19.3%3.6%3.2 $43.54 2/28/2023590,600 shares $31.43 million -3.3%3.0%2.7 $53.22 2/15/2023610,900 shares $34.66 million -4.8%3.2%3.3 $56.74 1/31/2023641,900 shares $37.60 million +7.4%3.4%3.3 $58.57 1/15/2023597,900 shares $29.39 million +4.1%3.2%3.1 $49.16 12/30/2022574,400 shares $27.58 million -0.2%3.1%2.6 $48.02 12/15/2022575,600 shares $28.60 million -3.3%3.1%2.6 $49.68 11/30/2022595,100 shares $29.66 million -16.2%3.3%2.6 $49.84 11/15/2022709,900 shares $31.78 million -1.8%4.0%3.2 $44.76 10/31/2022723,100 shares $36.40 million -4.1%4.1%3.3 $50.34 10/15/2022754,100 shares $33.13 million +12.8%4.6%3.4 $43.93 9/30/2022668,300 shares $25.14 million -4.6%4.0%3.2 $37.62 9/15/2022700,600 shares $27.81 million +3.2%4.2%3.4 $39.70 8/31/2022678,900 shares $24.01 million -12.5%4.3%3.1 $35.37“Crash Insurance” For Your Retirement (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. KROS Short Interest - Frequently Asked Questions What is Keros Therapeutics' current short interest? Short interest is the volume of Keros Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 2,260,000 shares of KROS short. Learn More on Keros Therapeutics' current short interest. What is a good short interest ratio for Keros Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KROS shares currently have a short interest ratio of 6.0. Learn More on Keros Therapeutics's short interest ratio. Is Keros Therapeutics' short interest increasing or decreasing? Keros Therapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 2,260,000 shares, an increase of 7.6% from the previous total of 2,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Keros Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Keros Therapeutics: Rocket Pharmaceuticals, Inc. (12.12%), Deciphera Pharmaceuticals, Inc. (11.45%), Amphastar Pharmaceuticals, Inc. (11.01%), Ardelyx, Inc. (14.50%), Amneal Pharmaceuticals, Inc. (2.51%), Maravai LifeSciences Holdings, Inc. (5.93%), Edgewise Therapeutics, Inc. (9.15%), Syndax Pharmaceuticals, Inc. (11.30%), NewAmsterdam Pharma (0.85%), Dyne Therapeutics, Inc. (10.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Keros Therapeutics stock? Short selling KROS is an investing strategy that aims to generate trading profit from Keros Therapeutics as its price is falling. KROS shares are trading down $0.40 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Keros Therapeutics? A short squeeze for Keros Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KROS, which in turn drives the price of the stock up even further. How often is Keros Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KROS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: RCKT Short Interest Data DCPH Short Interest Data AMPH Short Interest Data ARDX Short Interest Data AMRX Short Interest Data MRVI Short Interest Data EWTX Short Interest Data SNDX Short Interest Data NAMS Short Interest Data DYN Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KROS) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorFidelity, Bezos, Goldman Bet Big on Tiny BiotechBehind the MarketsAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily